Cargando…

Can PSMA-Targeting Radiopharmaceuticals Be Useful for Detecting Hepatocellular Carcinoma Using Positron Emission Tomography? An Updated Systematic Review and Meta-Analysis

Background: Several studies proposed the use of positron emission tomography (PET) with Prostate-Specific Membrane Antigen (PSMA)-targeting radiopharmaceuticals in hepatocellular carcinoma (HCC). Our aim is to calculate the detection rate (DR) of this examination in HCC with a meta-analysis. Methods...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rizzo, Alessio, Racca, Manuela, Albano, Domenico, Dondi, Francesco, Bertagna, Francesco, Annunziata, Salvatore, Treglia, Giorgio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699564/ https://www.ncbi.nlm.nih.gov/pubmed/36355540 http://dx.doi.org/10.3390/ph15111368

Ejemplares similares

The Emerging Role of PET/CT with PSMA-Targeting Radiopharmaceuticals in Clear Cell Renal Cancer: An Updated Systematic Review
por: Rizzo, Alessio, et al.
Publicado: (2023)

Diagnostic Performance of Positron Emission Tomography with Fibroblast-Activating Protein Inhibitors in Gastric Cancer: A Systematic Review and Meta-Analysis
por: Rizzo, Alessio, et al.
Publicado: (2023)

Potential Role of PSMA-Targeted PET in Thyroid Malignant Disease: A Systematic Review
por: Rizzo, Alessio, et al.
Publicado: (2023)

Diagnostic Accuracy of PET/CT or PET/MRI Using PSMA-Targeting Radiopharmaceuticals in High-Grade Gliomas: A Systematic Review and a Bivariate Meta-Analysis
por: Muoio, Barbara, et al.
Publicado: (2022)

Paget Disease as Common Pitfall on PET with Different Radiopharmaceuticals in Oncology: Not All That Glitters Is Gold!
por: Dondi, Francesco, et al.
Publicado: (2022)

Bone Scintigraphy versus PSMA-Targeted PET/CT or PET/MRI in Prostate Cancer: Lessons Learned from Recent Systematic Reviews and Meta-Analyses
por: Dondi, Francesco, et al.
Publicado: (2022)

Could [(18)F]FDG PET/CT or PET/MRI Be Useful in Patients with Skull Base Osteomyelitis?
por: Dondi, Francesco, et al.
Publicado: (2022)

Role of 2-[(18)F]FDG as a Radiopharmaceutical for PET/CT in Patients with COVID-19: A Systematic Review
por: Annunziata, Salvatore, et al.
Publicado: (2020)

(18)F-FDG PET/CT Maximum Tumor Dissemination (Dmax) in Lymphoma: A New Prognostic Factor?
por: Albano, Domenico, et al.
Publicado: (2023)

Prevalence of Brain Incidental Lesions Detected by (68)Ga-DOTA Peptides PET/CT
por: Albano, Domenico, et al.
Publicado: (2022)

Emerging Role of FAPI PET Imaging for the Assessment of Benign Bone and Joint Diseases
por: Dondi, Francesco, et al.
Publicado: (2022)

The Role of [(68)Ga]Ga-Pentixafor PET/CT or PET/MRI in Lymphoma: A Systematic Review
por: Albano, Domenico, et al.
Publicado: (2022)

A Rare Case of Incidental Finding of Cervical Spinal Cord Hemangioblastoma by (68)Ga-DOTATOC Positron Emission Tomography/Computed Tomography Scan
por: Bellini, Pietro, et al.
Publicado: (2022)

Diagnostic Performance of Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography in the Postchemotherapy Management of Patients with Seminoma: Systematic Review and Meta-Analysis
por: Treglia, Giorgio, et al.
Publicado: (2014)

Potential of Radiolabeled PSMA PET/CT or PET/MRI Diagnostic Procedures in Gliomas/Glioblastomas
por: Bertagna, Francesco, et al.
Publicado: (2020)

PSMA Radioligand Uptake as a Biomarker of Neoangiogenesis in Solid Tumours: Diagnostic or Theragnostic Factor?
por: Rizzo, Alessio, et al.
Publicado: (2022)

Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography in Assessing Retroperitoneal Fibrosis: A Literature Review
por: Treglia, Giorgio, et al.
Publicado: (2012)

Relationship between Baseline [(18)F]FDG PET/CT Semiquantitative Parameters and BRCA Mutational Status and Their Prognostic Role in Patients with Invasive Ductal Breast Carcinoma
por: Dondi, Francesco, et al.
Publicado: (2022)

Longitudinal Body Composition Changes Detected by [(18)F]FDG PET/CT during and after Chemotherapy and Their Prognostic Role in Elderly Hodgkin Lymphoma
por: Albano, Domenico, et al.
Publicado: (2022)

Role of Radiomics Features and Machine Learning for the Histological Classification of Stage I and Stage II NSCLC at [(18)F]FDG PET/CT: A Comparison between Two PET/CT Scanners
por: Dondi, Francesco, et al.
Publicado: (2022)

The “Undetermined Significance” of (18)F-FDG PET/CT or PET/MRI in Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS)
por: Treglia, Giorgio, et al.
Publicado: (2021)

Diagnostic Performance of PET Imaging Using Different Radiopharmaceuticals in Prostate Cancer According to Published Meta-Analyses
por: Annunziata, Salvatore, et al.
Publicado: (2020)

Comparison between total thyroidectomy and hemithyroidectomy in TIR3B thyroid nodules management
por: Albano, Domenico, et al.
Publicado: (2022)

Prevalence of Incidental Findings Suspicious for Transthyretin Cardiac Amyloidosis among Patients Undergoing Bone Scintigraphy: A Systematic Review and a Meta-Analysis
por: Treglia, Giorgio, et al.
Publicado: (2023)

Incidental Unilateral Tuberculous Sacroiliitis Detected by (18)F-FDG PET/CT in a Patient with Abdominal Tuberculosis
por: Albano, Domenico, et al.
Publicado: (2017)

PET with Different Radiopharmaceuticals in Neuroendocrine Neoplasms: An Umbrella Review of Published Meta-Analyses
por: Treglia, Giorgio, et al.
Publicado: (2021)

Temporal Evolution and Prognostic Role of Indeterminate Response Sub-Groups in Patients with Differentiated Thyroid Cancer after Initial Therapy with Radioiodine
por: Albano, Domenico, et al.
Publicado: (2023)

Usefulness of Whole-Body Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography in Patients with Neurofibromatosis Type 1: A Systematic Review
por: Treglia, Giorgio, et al.
Publicado: (2012)

PET/CT and Conventional Imaging for the Assessment of Neuroendocrine Prostate Cancer: A Systematic Review
por: Dondi, Francesco, et al.
Publicado: (2023)

(18)F-FDG PET and PET/CT for the evaluation of gastric signet ring cell carcinoma: a systematic review
por: Dondi, Francesco, et al.
Publicado: (2021)

Chelators for copper radionuclides in positron emission tomography radiopharmaceuticals()
por: Cai, Zhengxin, et al.
Publicado: (2013)

Current Radiopharmaceuticals for Positron Emission Tomography of Brain Tumors
por: Jung, Ji-hoon, et al.
Publicado: (2018)

Positron Emission Tomography (PET) Radiopharmaceuticals in Multiple Myeloma
por: Sachpekidis, Christos, et al.
Publicado: (2019)

Positron Emission Tomography Radiopharmaceuticals in Differentiated Thyroid Cancer
por: Sakulpisuti, Chaninart, et al.
Publicado: (2022)

The Role of Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography in Aggressive Histological Subtypes of Thyroid Cancer: An Overview
por: Treglia, Giorgio, et al.
Publicado: (2013)

(18)F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Interpretation Criteria for the Assessment of Therapeutic Response in Patients with Advanced Stage of Lung Cancer: Inter-Reader Reliability, Accuracy, and Survival Outcomes
por: Mazzoletti, Angelica, et al.
Publicado: (2022)

Quality control of positron emission tomography radiopharmaceuticals: An institutional experience
por: Shukla, Jaya, et al.
Publicado: (2013)

Positron emission tomography: Evolving modalities, radiopharmaceuticals and professional collaboration
por: Ayesa, Sally L., et al.
Publicado: (2022)

Assessment of radiopharmaceutical retention for vascular access ports using positron emission tomography imaging
por: Gossman, Michael S., et al.
Publicado: (2017)

Diagnostic Performance of Positron Emission Tomography/Computed Tomography Using Fluorine-18 Fluorodeoxyglucose in Detecting Locoregional Nodal Involvement in Patients with Anal Canal Cancer: A Systematic Review and Meta-Analysis
por: Caldarella, Carmelo, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_a2v1gr3t4ji01johtgpjktrga9